- 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma
-
Korean Liver Cancer Study Group (KLCSG), National Cancer Center, Korea (NCC)
- KMID: 2155638
- Gut Liver.
- 2015 May;9(3):267-317.
- doi: 10.5009/gnl14460
The guideline for the management of hepatocellular carcinoma (HCC) was first developed in 2003 and revised in 2009 by the Korean Liver Cancer Study Group and the National Cancer Center,... -
- CITED
-
- Close
- SHARE
-
- Close
- Practice Guideline for Diagnosis and Treatment of Hepatocellular Carcinoma
-
Park JW
- KMID: 760536
- Korean J Hepatol.
- 2004 Jun;10(2):88-98.
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is the 3rd most common cancer. The annual incidence is over 10,000 cases in Korea. While hepatitis B virus is major cause of Korean HCC,... -
- CITED
-
- Close
- SHARE
-
- Close
- Experimental Treatment of Hepatocellular Carcinoma
-
Choi JY
- KMID: 772764
- Korean J Gastroenterol.
- 2005 Apr;45(4):271-276.
Hepatocellular carcinoma (HCC) is one of the most common malignancies world wide. Several experimental treatments have been tested against HCC. Those are chemotherapy, high dose proton beam radiotherapy, external beam... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Resection of Biloma with Hepatocellular Carcinoma after Embolization.
-
Park WK, Chang JC, Lee HZ, Kim HJ, Choi JH, Gu MJ
- KMID: 863106
- Korean J Hepatol.
- 2002 Sep;8(3):331-335.
Intrahepatic biloma is one of the rare complications occurring after transcatheter arterial chemoembolization (TACE). Biloma after TACE may result from the development of peripheral bile duct necrosis caused by... -
- CITED
-
- Close
- SHARE
-
- Close
- Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization
-
Yoo SH, Jang JW, Kwon JH, Jung SM, Jang B, Choi JY
- KMID: 2373150
- Clin Mol Hepatol.
- 2016 Dec;22(4):458-465.
- doi: 10.3350/cmh.2016.0054
BACKGROUND/AIMS: Hepatic damage during transarterial chemoembolization (TACE) is a critical complication in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Apart from its role in preventing HBV reactivation, there... -
- CITED
-
- Close
- SHARE
-
- Close
- Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
-
Woo HY, Heo J
- KMID: 2359814
- Clin Mol Hepatol.
- 2015 Dec;21(4):344-348.
- doi: 10.3350/cmh.2015.21.4.344
Transarterial chemoembolization (TACE) using doxorubicin-eluting beads (DEBs) have been introduced as a novel device which ensures more sustained and tumor-selective drug delivery and permanent embolization compared to conventional TACE with... -
- CITED
-
- Close
- SHARE
-
- Close
- The Current Practice of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
-
Shin SW
- KMID: 1093956
- Korean J Radiol.
- 2009 Oct;10(5):425-434.
- doi: 10.3348/kjr.2009.10.5.425
Despite remarkable advancement in the surveillance and treatment of hepatocellular carcinoma (HCC) and the availability of novel curative options, a great proportion of HCC patients are still not eligible for... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of hepatocellular carcinoma in the caudate lobe successfully treated by transcatheter arterial chemoembolization using drug-eluting beads
-
Joh DH, Kim JD, Kim YN, Song HH, Kim H, Song KH, Lee SJ, Lee JR, Jeon WJ, Cha BH
- KMID: 1117699
- Korean J Hepatol.
- 2010 Dec;16(4):405-409.
- doi: 10.3350/kjhep.2010.16.4.405
Hepatocellular carcinoma (HCC) in the caudate lobe remains one of the most intricate locations where various treatments tend to pose problems with regard to the optimal approach. Surgical resection has... -
- CITED
-
- Close
- SHARE
-
- Close
